Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios.
Interstitial lung disease
Non–small cell lung cancer
Oligometastatic
Reirradiation
Stereotactic body radiation therapy
Ultracentral
Journal
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
03
03
2021
revised:
02
04
2021
accepted:
07
04
2021
pubmed:
27
4
2021
medline:
10
8
2021
entrez:
26
4
2021
Statut:
ppublish
Résumé
Stereotactic body radiation therapy (SBRT) is an effective and well-tolerated treatment for medically inoperable patients with early stage NSCLC. SBRT is a noninvasive treatment involving the delivery of ablative radiation doses with high precision in the course of a few treatments. Relative to conventionally fractionated radiation, SBRT achieves superior local control and survival. SBRT use has increased dramatically in the past 15 years and is currently considered the standard of care in cases of inoperable early stage NSCLC. It is being increasingly applied to more complex patient populations at higher risk of treatment-related toxicity. In these more complex patients, there is an increasing need to balance patient and treatment factors in selecting the optimal patients for SBRT. Here, we review several challenging clinical scenarios often encountered in thoracic multidisciplinary tumor boards.
Identifiants
pubmed: 33901637
pii: S1556-0864(21)02112-2
doi: 10.1016/j.jtho.2021.04.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1075-1085Informations de copyright
Crown Copyright © 2021. Published by Elsevier Inc. All rights reserved.